These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7256085)

  • 1. An epidemiologic approach to pneumococcal disease.
    Riley ID; Douglas RM
    Rev Infect Dis; 1981; 3(2):233-45. PubMed ID: 7256085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal vaccine trials in Papua New Guinea: relationships between epidemiology of pneumococcal infection and efficacy of vaccine.
    Riley ID; Lehmann D; Alpers MP
    Rev Infect Dis; 1991; 13 Suppl 6():S535-41. PubMed ID: 1862283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiologic and serologic studies of pneumococcal infections with reference to the new STIKO recommendations].
    Hülsse C; Littmann M; Fiedler K; Kaltofen U; Hundt C
    Gesundheitswesen; 1999; 61(8-9):393-7. PubMed ID: 10535219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.
    Finkelstein JA; Huang SS; Daniel J; Rifas-Shiman SL; Kleinman K; Goldmann D; Pelton SI; DeMaria A; Platt R
    Pediatrics; 2003 Oct; 112(4):862-9. PubMed ID: 14523178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
    Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
    Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon.
    Frazão N; Brito-Avô A; Simas C; Saldanha J; Mato R; Nunes S; Sousa NG; Carriço JA; Almeida JS; Santos-Sanches I; de Lencastre H
    Pediatr Infect Dis J; 2005 Mar; 24(3):243-52. PubMed ID: 15750461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.
    Jones N; Huebner R; Khoosal M; Crewe-Brown H; Klugman K
    AIDS; 1998 Nov; 12(16):2177-84. PubMed ID: 9833859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal disease in Sweden: experiences and current situation.
    Ortqvist A
    Am J Med; 1999 Jul; 107(1A):44S-49S. PubMed ID: 10451008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme.
    Levidiotou S; Vrioni G; Tzanakaki G; Pappa C; Gesouli H; Gartzonika C; Papamichail D; Kremastinou J
    FEMS Immunol Med Microbiol; 2006 Nov; 48(2):179-82. PubMed ID: 17064274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR).
    Daana M; Rahav G; Hamdan A; Thalji A; Jaar F; Abdeen Z; Jaber H; Goral A; Huppert A; Raz M; Regev-Yochay G;
    Vaccine; 2015 Feb; 33(8):1021-6. PubMed ID: 25593104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal disease and its prevention with polyvalent pneumococcal polysaccharide vaccines--a review.
    Douglas RM; Riley ID
    Aust N Z J Med; 1979 Jun; 9(3):327-38. PubMed ID: 37823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of nasopharyngeal colonization by Streptococcus pneumoniae and its antibiotics resistance in healthy children less than 2 years of age in the Marrakech region (Morocco)].
    Bouskraoui M; Soraa N; Zahlane K; Arsalane L; Doit C; Mariani P; Bingen E
    Arch Pediatr; 2011 Dec; 18(12):1265-70. PubMed ID: 21978670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pneumococcal pneumonia: epidemiology, therapy, immunoprophylaxis].
    Gartmann J
    Schweiz Med Wochenschr; 1980 Aug; 110(35):1258-65. PubMed ID: 6903401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial.
    Zangwill KM; Vadheim CM; Vannier AM; Hemenway LS; Greenberg DP; Ward JI
    J Infect Dis; 1996 Oct; 174(4):752-9. PubMed ID: 8843213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
    Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
    Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.
    Kovács E; Sahin-Tóth J; Tóthpál A; Kristóf K; van der Linden M; Tirczka T; Dobay O
    Vaccine; 2019 Jan; 37(1):99-108. PubMed ID: 30470639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
    Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
    Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevenar experience.
    Arguedas A; Soley C; Abdelnour A
    Vaccine; 2011 Sep; 29 Suppl 3():C26-34. PubMed ID: 21896350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.